CAU
CHE icon

Caxton Associates (UK)’s Chemed CHE Stock Holding History

Caxton Associates (UK)’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
5,601
+3,109
+125% +$1.31M 0.05% 198
2026
Q1 		$941K Sell
2,492
-293
-11% -$125K 0.02% 389
2025
Q4 		$1.19M Buy
+2,785
New +$1.21M 0.02% 319

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Caxton Associates (UK)'s CHE Position: Q2 2026 in Review

Caxton Associates (UK) increased its Chemed (CHE) stake by 125% in Q2 2026, buying an estimated $1.31M and bringing the position to 5,601 shares worth $2.61M. The position accounts for 0.05% of the portfolio, ranked #198.

Caxton Associates (UK) first reported a position in CHE in Q4 2025 and has held it in 3 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Caxton Associates (UK) held 5,601 shares of Chemed worth $2.61M as of Q2 2026.
  • Caxton Associates (UK) bought 3,109 Chemed shares in Q2 2026, an estimated $1.31M.
  • Chemed made up 0.05% of Caxton Associates (UK)'s portfolio in Q2 2026, its #198 holding.
  • Caxton Associates (UK) first reported a position in Chemed in Q4 2025 and has held it in 3 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.